Trametinib is an active pharmaceutical ingredient that functions as a MEK inhibitor. It is primarily used in the manufacturing of anticancer medications for conditions such as melanoma and glioma.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Trametinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
(R)-etodolac
pharmaceutical raw material
Emedastine difumarate
pharmaceutical raw material
Cefpodoxime proxetil
pharmaceutical raw material
(S)-etodolac
pharmaceutical raw material
The international HS code for Trametinib (CAS 871700-17-3) is 2933.79.
2933.79
2933 79 00
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
N-[3-[3-cyclopropyl-5-(2-fluoro-4-iodoanilino)-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1-yl]phenyl]acetamide
LIRYPHYGHXZJBZ-UHFFFAOYSA-N
CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5
Sourcing Trametinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.